Juno Therapeutics, A Subsidiary Of Celgene

This study tests a treatment called JCAR017, a type of CAR T-cell therapy, for people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has come back or not responded to other treatments. The therapy uses a patient's own immune cells, which are modi…

This program provides access to a CAR-T cell therapy called lisocabtagene maraleucel (liso-cel) that didn't meet all commercial quality standards. It is for adults with large B-cell lymphoma who were already prescribed liso-cel as part of their care. Patients receive chemotherapy…